KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Other Operating Expenses (2018 - 2025)

Vir Biotechnology's Other Operating Expenses history spans 7 years, with the latest figure at $26000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 100.8% year-over-year to $26000.0; the TTM value through Dec 2025 reached -$156000.0, down 100.44%, while the annual FY2025 figure was -$156000.0, 100.44% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $26000.0 at Vir Biotechnology, up from -$11000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $90.1 million in Q1 2022 and bottomed at -$3.3 million in Q4 2024.
  • The 5-year median for Other Operating Expenses is $1.9 million (2023), against an average of $13.5 million.
  • The largest annual shift saw Other Operating Expenses soared 119568.18% in 2024 before it tumbled 190.91% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $56.9 million in 2021, then crashed by 89.46% to $6.0 million in 2022, then grew by 22.67% to $7.4 million in 2023, then plummeted by 144.32% to -$3.3 million in 2024, then skyrocketed by 100.8% to $26000.0 in 2025.
  • Per Business Quant, the three most recent readings for VIR's Other Operating Expenses are $26000.0 (Q4 2025), -$11000.0 (Q3 2025), and -$161000.0 (Q2 2025).